A look into the future of laboratory automation

What does the future of Lab Automation look like in the drug discovery market? No one knows for sure. Where are we going with technologies like artificial intelligence and machine learning? And what about data storage in the cloud, privacy and security. What will the life cycle of a sample look like in the near future and how will we collaborate with robots? 

Genmab, an international biotechnology company, specializes in creating and developing distinctive therapeutic human antibodies for the treatment of cancer. The Lab Automation team within Genmab is responsible for the human-friendly automation of laboratory processes. Cutting-edge technologies are introduced and maintained. Processing and sharing data is central to this. Automation plays a key role in state-of-the-art drug development. Martin Bosch, Lab Automation expert at Genmab, will take you through their vision on the future of Lab Automation in his presentation.

Martijn Bosch's presentation will take place at 4:00 PM. Don't miss it and register now in for LabAutomation 2019!